HEMODYNAMICS IN TRANSGENIC MICE WITH OVEREXPRESSION OF ATRIAL-NATRIURETIC-FACTOR

被引:65
|
作者
BARBEE, RW
PERRY, BD
RE, RN
MURGO, JP
FIELD, LJ
机构
[1] ALTON OCHSNER MED FDN & OCHSNER CLIN, CARDIOL SECT, NEW ORLEANS, LA 70121 USA
[2] INDIANA UNIV, SCH MED, KRANNERT INST CARDIOL, INDIANAPOLIS, IN 46202 USA
关键词
BLOOD PRESSURE; BLOOD VOLUME; CARDIAC OUTPUT; VASCULAR RESISTANCE; AUTOREGULATION; ATRIAL NATRIURETIC FACTOR;
D O I
10.1161/01.RES.74.4.747
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The circulatory effects associated with lifelong plasma atrial natriuretic factor (ANF) elevation were examined by generating transgenic mice, which constitutively express a fusion gene consisting of the transthyretin promoter and the ANF structural gene. These mice have chronically elevated ANF levels as compared with their nontransgenic siblings. Transgenic animals exhibited immunoreactive ANF levels that were nearly fivefold higher than those measured in nontransgenic littermates. Systemic and regional hemodynamics and blood volumes were explored by using modifications of the reference microsphere and dilution techniques. Mean arterial pressure was reduced by 24 mm Hg, associated with a 27% reduction in total heart weight. This chronic reduction in blood pressure was due to a 21% reduction in total peripheral resistance, whereas cardiac output, stroke volume, and heart rate were not significantly altered, despite a 15% elevation in plasma volume. Transgenic mice displayed reductions of 35%, 33%, 32%, and 19% in muscle, skin, brain, and renal vascular resistance, respectively, whereas coronary and splanchnic resistances were not significantly altered. The findings complement earlier data from chronically infused normotensive mammals and suggest that these mice are an excellent model for investigating the effects of lifelong ANF elevation.
引用
收藏
页码:747 / 751
页数:5
相关论文
共 50 条
  • [41] ATRIAL-NATRIURETIC-FACTOR, CATECHOLAMINES, AND NATRIURESIS
    RACZ, K
    KUCHEL, O
    BUU, NT
    DEBINSKI, W
    CANTIN, M
    GENEST, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (05): : 321 - 322
  • [42] ATRIAL-NATRIURETIC-FACTOR INHIBITS HYPERTONIC SALINE-MEDIATED DECREASES IN RENAL HEMODYNAMICS
    LOFTUS, JP
    REDFIELD, MM
    BURNETT, JC
    KIDNEY INTERNATIONAL, 1990, 38 (02) : 227 - 231
  • [43] HUMAN STUDIES WITH ATRIAL-NATRIURETIC-FACTOR
    NICHOLLS, MG
    RICHARDS, AM
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1987, 16 (01) : 199 - 223
  • [44] ATRIAL-NATRIURETIC-FACTOR AND CORTICOSTEROID BIOSYNTHESIS
    VARGA, I
    KISS, R
    RACZ, K
    GLAZ, E
    ACTA PHYSIOLOGICA HUNGARICA, 1986, 68 (3-4) : 333 - 333
  • [45] ATRIAL-NATRIURETIC-FACTOR - IS IT PHYSIOLOGICALLY IMPORTANT
    BURNETT, JC
    CIRCULATION, 1990, 82 (04) : 1523 - 1524
  • [46] ATRIAL-NATRIURETIC-FACTOR AND THE ANTERIOR HYPOPHYSIS
    MOREL, G
    CHABOT, JG
    DIHL, F
    BELLESISLES, M
    HEISLER, S
    BIOLOGY OF THE CELL, 1987, 60 (01) : A8 - A8
  • [47] ATRIAL-NATRIURETIC-FACTOR - A VENTRICULAR HORMONE
    PASTERNAC, A
    CANTIN, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 15 (06) : 1446 - 1448
  • [48] THERAPEUTIC USE OF ATRIAL-NATRIURETIC-FACTOR
    CONNELL, JMC
    JARDINE, AG
    NORTHRIDGE, DB
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 34 (02) : 102 - 105
  • [49] ATRIAL-NATRIURETIC-FACTOR AND THE EXOCRINE PANCREAS
    HEISLER, S
    CHABOT, JG
    BELLESISLES, M
    KOPELAND, H
    MOREL, G
    BIOLOGY OF THE CELL, 1987, 60 (01) : A7 - A7
  • [50] ATRIAL-NATRIURETIC-FACTOR IN EDEMATOUS DISORDERS
    CODY, RJ
    ANNUAL REVIEW OF MEDICINE, 1990, 41 : 377 - 382